Haematological Indicators of Response to Erythropoietin Therapy in Chronic Renal Failure Patients on Haemodialysis: Impact of Angiotensin-Converting Enzyme rs4343 Gene Polymorphism

PURPOSE: This is the first cross-sectional study studying the changes in haematological indicators of the response to recombinant human erythropoietin (rHuEPO) therapy in chronic renal failure (CRF) patients on haemodialysis (HD) stratified according to ACE G2350A (rs4343) gene polymorphism. DESIGN:...

Descripción completa

Detalles Bibliográficos
Autores principales: Hamdan Almaeen, Abdulrahman, Mostafa-Hedeab, Gomaa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8408344/
https://www.ncbi.nlm.nih.gov/pubmed/34483678
http://dx.doi.org/10.2147/PGPM.S311181

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8408344/
https://www.ncbi.nlm.nih.gov/pubmed/34483678
http://dx.doi.org/10.2147/PGPM.S311181

Ejemplares similares